Advances in neurofibromatosis 2 (NF2): a workshop report

J Neurogenet. 2000 Jun;14(2):63-106. doi: 10.3109/01677060009083477.
No abstract available

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Adult
  • Age of Onset
  • Animals
  • Antineoplastic Agents / therapeutic use
  • Carrier Proteins / physiology
  • Cataract / genetics
  • Cells, Cultured
  • Chromosomes, Human, Pair 22 / genetics
  • Clinical Trials as Topic
  • DNA Mutational Analysis
  • Disease Models, Animal
  • Disease Progression
  • Drosophila melanogaster / genetics
  • Female
  • Gene Expression
  • Gene Targeting
  • Genes, Insect
  • Genes, Neurofibromatosis 2
  • Genetic Therapy
  • Genotype
  • Goals
  • Hamartoma / genetics
  • Humans
  • Insect Proteins / genetics
  • Macromolecular Substances
  • Male
  • Membrane Proteins / chemistry
  • Membrane Proteins / genetics
  • Membrane Proteins / physiology
  • Meningeal Neoplasms / genetics
  • Meningioma / genetics
  • Mice
  • Mice, Mutant Strains
  • Microfilament Proteins / genetics
  • Microfilament Proteins / physiology
  • Models, Animal
  • Mosaicism
  • Neurofibromatosis 2* / epidemiology
  • Neurofibromatosis 2* / genetics
  • Neurofibromatosis 2* / pathology
  • Neurofibromatosis 2* / therapy
  • Neurofibromin 2
  • Neuroma, Acoustic / genetics
  • Phenotype
  • Protein Isoforms / chemistry
  • Protein Isoforms / physiology
  • Retinal Diseases / genetics
  • Schwann Cells / cytology
  • Skin Neoplasms / genetics
  • Spinal Neoplasms / genetics

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • Insect Proteins
  • Macromolecular Substances
  • Membrane Proteins
  • Microfilament Proteins
  • Neurofibromin 2
  • Protein Isoforms
  • fodrin
  • merlin, Drosophila
  • moesin